Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03125083Completed
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoints: Difference in IDO activation at Day 1 and Difference in neurotransmitters synthesis inhibition at Day 1. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03125083.